- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biofrontera Inc (BFRI)
Assess today's live Biofrontera Inc (BFRI) share price, performance and insights using our live NASDAQ: BFRI stock exchange data.
Analyse the historical data and Biofrontera Inc share price performance charts on this page. Our technical summary section provides analysis on Biofrontera share price buy/sell indicators using real-time data (or discuss the Biofrontera (BFRI) stock price today with other investors in the Biofrontera NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ BFRI share price (ISIN: US09077D2099) to enhance your trading decisions with our free investment tools and resources.
What Is the Biofrontera Inc Share Price Today?
The Biofrontera share price today is 0.8294.
What Is the Stock Symbol for Biofrontera Inc
The stock symbol (or 'ticker') for Biofrontera Inc is "BFRI."
What Stock Exchange Does Biofrontera Inc Trade On?
Biofrontera Inc is listed and trades on the NASDAQ stock exchange.
Is Biofrontera Inc a Good Stock to Buy?
Determining whether Biofrontera Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Biofrontera Inc share price performance charts on this page. Our technical summary section provides analysis on Biofrontera share price buy/sell indicators using real-time data (or discuss the Biofrontera (BFRI) stock price today with other investors in the Biofrontera NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ BFRI share price (ISIN: US09077D2099) to enhance your trading decisions with our free investment tools and resources.
What Is the Biofrontera Inc Share Price Today?
The Biofrontera share price today is 0.8294.
What Is the Stock Symbol for Biofrontera Inc
The stock symbol (or 'ticker') for Biofrontera Inc is "BFRI."
What Stock Exchange Does Biofrontera Inc Trade On?
Biofrontera Inc is listed and trades on the NASDAQ stock exchange.
Is Biofrontera Inc a Good Stock to Buy?
Determining whether Biofrontera Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
0.8294
-0.0262(-3.06%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8015
0.8640
52 wk Range
0.5360
1.1900
BFRI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.80150.8640
52 wk Range
0.53601.1900
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BFRI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
6.0000
Upside
+623.41%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low revenue valuation multiple
- Form 8K Biofrontera Inc For: 26 February
- Investing.com
- Form 8K Biofrontera Inc For: 10 March
- Investing.com
- Form 8K Biofrontera Inc For: 10 March
- Investing.com
- Form 4 Biofrontera Inc For: 6 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Biofrontera Inc Earnings Call Summary for Q4/2025
- Biofrontera reported record Q4 2025 revenue of $17.1M, up 36% YoY, and achieved first profitable quarter with $5.6M net income.
- Strategic transaction with Biofrontera AG drove 45% decrease in COGS and improved gross profit margin to 82% from 58% in Q4 2024.
- Adjusted EBITDA reached $4.9M with 29% margin; company expects full annualized cost structure benefits to materialize in 2026.
- Stock rose 7.07% to $0.93 in premarket trading, reflecting investor confidence in operational efficiency and expanded product pipeline.
- Management projects continued revenue growth driven by pending FDA approvals for new Ameluz indications and enhanced market position in photodynamic therapy.
Last Updated: 19/03/2026, 14:52
Read Full TranscriptCompare BFRI to Peers and Sector
Metrics to compare | BFRI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBFRIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.9x | −18.5x | −0.5x | |
PEG Ratio | −0.01 | 0.05 | 0.00 | |
Price/Book | 0.9x | 1.7x | 2.6x | |
Price / LTM Sales | 0.2x | 2.2x | 3.1x | |
Upside (Analyst Target) | - | 95.2% | 55.6% | |
Fair Value Upside | Unlock | 16.4% | 8.6% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.0000
(+623.41% Upside)
Earnings
Latest Release
12/11/2025
EPS / Forecast
-0.62 / -0.57
Revenue / Forecast
6.99M / --
People Also Watch
FAQ
What Is the Biofrontera (BFRI) Share Price Today?
The Biofrontera stock price today is 0.8294 USD.
What Stock Exchange Does Biofrontera (BFRI) Trade On?
Biofrontera is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Biofrontera?
The stock symbol (also called a 'ticker') for Biofrontera is "BFRI."
What Is the Current Biofrontera Market Cap?
As of today, Biofrontera market cap is 9.9700M USD.
What Is Biofrontera's (BFRI) Earnings Per Share (TTM)?
The Biofrontera EPS is currently -1.9200 (Trailing Twelve Months).
Is BFRI a Buy or Sell From a Technical Analyst Perspective?
Based on today's Biofrontera moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Biofrontera Stock Split?
Biofrontera has split 1 times. (See the BFRI stock split history page for full effective split date and price information.)
How Many Employees Does Biofrontera Have?
Biofrontera has 93 employees.
What is the current trading status of Biofrontera (BFRI)?
As of 20/03/2026, Biofrontera (BFRI) is trading at a price of 0.8294 USD, with a previous close of 0.8556 USD. The stock has fluctuated within a day range of 0.8015 USD to 0.8640 USD, while its 52-week range spans from 0.5360 USD to 1.1900 USD.
What Is Biofrontera (BFRI) Price Target According to Analysts?
The average 12-month price target for Biofrontera is 6.0000 USD, with a high estimate of 9 USD and a low estimate of 3 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +623.41% Upside potential.
What Is the BFRI Premarket Price?
BFRI's last pre-market stock price is 0.8364 USD. The pre-market share volume is 8,270.0000, and the stock has decreased by -0.0192, or -2.2400%.
What Is the BFRI After Hours Price?
BFRI's last after hours stock price is 0.8639 USD, the stock has decreased by 0.0083, or 0.9700%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.